PACE Case: Avoiding Competitive Inhibition and Evaluating Therapeutic Benefits in Older Adults Read More »
Opioids, Polypharmacy, and Drug Interactions: A Technological Paradigm Shift Is Needed to Ameliorate the Ongoing Opioid Epidemic Read More »
PACE Case: Mitigating Pharmacokinetic Multi-Drug Interactions and Medication Adverse Effects Read More »
Risk of Adverse Drug Events Following the Virtual Addition of COVID-19 Repurposed Drugs to Drug Regimens of Frail Older Adults with Polypharmacy Read More »
PACE Case: Driving Improved Health Outcomes by Mitigating Competitive Inhibition and Potential Adverse Events Read More »
